Found: 22
Select item for more details and to access through your institution.
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 982, doi. 10.1002/ajh.27247
- By:
- Publication type:
- Article
Continuous venetoclax in treatment‐naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 9, p. E237, doi. 10.1002/ajh.27009
- By:
- Publication type:
- Article
PIEZO1 mutations impact on early clinical manifestations of myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E72, doi. 10.1002/ajh.26863
- By:
- Publication type:
- Article
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. 1037, doi. 10.1002/ajh.24842
- By:
- Publication type:
- Article
Zinc Status and Autoimmunity: A Systematic Review and Meta-Analysis.
- Published in:
- Nutrients, 2018, v. 10, n. 1, p. 68, doi. 10.3390/nu10010068
- By:
- Publication type:
- Article
A systematic analysis of bone marrow cells by flow cytometry defines a specific phenotypic profile beyond GPI deficiency in paroxysmal nocturnal hemoglobinuria.
- Published in:
- Cytometry. Part B, 2013, v. 84B, n. 2, p. 71, doi. 10.1002/cyto.b.21064
- By:
- Publication type:
- Article
Simultaneous determination of ten amphetamine designer drugs in human whole blood by capillary electrophoresis with diode array detection.
- Published in:
- Biomedical Chromatography, 2005, v. 19, n. 10, p. 737, doi. 10.1002/bmc.508
- By:
- Publication type:
- Article
TCL-361: Bendamustine as Front-Line Therapy in T-Cell Prolymphocytic Leukemia: A Monocentric Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S414, doi. 10.1016/S2152-2650(21)01931-5
- By:
- Publication type:
- Article
MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S344, doi. 10.1016/S2152-2650(21)01800-0
- By:
- Publication type:
- Article
Poster: TCL-361: Bendamustine as Front-Line Therapy in T-Cell Prolymphocytic Leukemia: A Monocentric Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S248, doi. 10.1016/S2152-2650(21)01561-5
- By:
- Publication type:
- Article
Poster: MDS-223: Response to Erythroid Stimulating Agents (ESA) and Flow Cytometric Characteristics of Bone Marrow Erythroid Precursors in IPSS-R Lower-Risk Myelodysplastic Syndrome Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S228, doi. 10.1016/S2152-2650(21)01440-3
- By:
- Publication type:
- Article
Flow cytometric analysis of erythroid precursors and mutational signatures of lower risk myelodysplastic syndromes identify responders to erythroid stimulating agents.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 4251, doi. 10.1007/s10238-023-01244-5
- By:
- Publication type:
- Article
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1033413
- By:
- Publication type:
- Article
Hepcidin Levels and Their Determinants in Different Types of Myelodysplastic Syndromes.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0023109
- By:
- Publication type:
- Article
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 5, p. 741, doi. 10.1111/bjh.14621
- By:
- Publication type:
- Article
Myelodysplastic syndromes with single neutropenia or thrombocytopenia are rarely refractory cytopenias with unilineage dysplasia by World Health Organization 2008 criteria and have favourable prognosis.
- Published in:
- British Journal of Haematology, 2016, v. 175, n. 5, p. 975, doi. 10.1111/bjh.13902
- By:
- Publication type:
- Article
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0163313
- By:
- Publication type:
- Article
Real-World Outcome of Treatment with Single-Agent Ibrutinib in Italian Patients with Chronic Lymphocytic Leukemia: Final Results of the EVIdeNCE Study.
- Published in:
- Cancers, 2024, v. 16, n. 6, p. 1228, doi. 10.3390/cancers16061228
- By:
- Publication type:
- Article
Real‐world evidence on venetoclax in chronic lymphocytic leukemia: The Italian experience.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 621, doi. 10.1002/hon.3122
- By:
- Publication type:
- Article
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221127550
- By:
- Publication type:
- Article
Zinc and Other Metals Deficiencies and Risk of Type 1 Diabetes: An Ecological Study in the High Risk Sardinia Island.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0141262
- By:
- Publication type:
- Article